# COVID-19 Supplemental work: NON-HUMAN PRIMATE MAJOR HISTOCOMPATIBILITY COMPLEX ALLELE DISCOVERY AND TYPING TECHNOLOGY DEVELOPMENT.

> **NIH NIH N01** · FRED HUTCHINSON CANCER RESEARCH CENTER · 2020 · $528,451

## Abstract

The study will validate a NGS-based COVID-19 detection system for unambiguous sequence-based reporting using residual materials / isolated total nucleic acids remaining after a RT-PCR based COVID-19 testing is performed.

## Key facts

- **NIH application ID:** 10260042
- **Project number:** 272201600027C-P00008-9999-3
- **Recipient organization:** FRED HUTCHINSON CANCER RESEARCH CENTER
- **Principal Investigator:** DANIEL E. GERAGHTY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $528,451
- **Award type:** —
- **Project period:** 2020-04-22 → 2020-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10260042

## Citation

> US National Institutes of Health, RePORTER application 10260042, COVID-19 Supplemental work: NON-HUMAN PRIMATE MAJOR HISTOCOMPATIBILITY COMPLEX ALLELE DISCOVERY AND TYPING TECHNOLOGY DEVELOPMENT. (272201600027C-P00008-9999-3). Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/grant/nih/10260042. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*